Leukocyte Surface Antigen CD47 Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Leukocyte Surface Antigen CD47 market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Leukocyte Surface Antigen CD47 market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Leukocyte Surface Antigen CD47 market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Leukocyte Surface Antigen CD47 market segmented into
- B-6H12
- ALX-148
- CC-90002
- PSTx-23
- Others
- Lymphoma
- Ovarian Cancer
- Ischemia Reperfusion Injury
- Kindney Transplant Rejection
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Aurigene Discovery Technologies Ltd
- Celgene Corp
- Forty Seven Inc
- Surface Oncology Inc
- Trillium Therapeutics Inc
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LEUKOCYTE SURFACE ANTIGEN CD47 INDUSTRY
2.1 Summary about Leukocyte Surface Antigen CD47 Industry
2.2 Leukocyte Surface Antigen CD47 Market Trends
2.2.1 Leukocyte Surface Antigen CD47 Production & Consumption Trends
2.2.2 Leukocyte Surface Antigen CD47 Demand Structure Trends
2.3 Leukocyte Surface Antigen CD47 Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 B-6H12
4.2.2 ALX-148
4.2.3 CC-90002
4.2.4 PSTx-23
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Lymphoma
4.3.2 Ovarian Cancer
4.3.3 Ischemia Reperfusion Injury
4.3.4 Kindney Transplant Rejection
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 B-6H12
5.2.2 ALX-148
5.2.3 CC-90002
5.2.4 PSTx-23
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Lymphoma
5.3.2 Ovarian Cancer
5.3.3 Ischemia Reperfusion Injury
5.3.4 Kindney Transplant Rejection
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 B-6H12
6.2.2 ALX-148
6.2.3 CC-90002
6.2.4 PSTx-23
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Lymphoma
6.3.2 Ovarian Cancer
6.3.3 Ischemia Reperfusion Injury
6.3.4 Kindney Transplant Rejection
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 B-6H12
7.2.2 ALX-148
7.2.3 CC-90002
7.2.4 PSTx-23
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Lymphoma
7.3.2 Ovarian Cancer
7.3.3 Ischemia Reperfusion Injury
7.3.4 Kindney Transplant Rejection
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 B-6H12
8.2.2 ALX-148
8.2.3 CC-90002
8.2.4 PSTx-23
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Lymphoma
8.3.2 Ovarian Cancer
8.3.3 Ischemia Reperfusion Injury
8.3.4 Kindney Transplant Rejection
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 B-6H12
9.2.2 ALX-148
9.2.3 CC-90002
9.2.4 PSTx-23
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Lymphoma
9.3.2 Ovarian Cancer
9.3.3 Ischemia Reperfusion Injury
9.3.4 Kindney Transplant Rejection
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Aurigene Discovery Technologies Ltd
10.1.2 Celgene Corp
10.1.3 Forty Seven Inc
10.1.4 Surface Oncology Inc
10.1.5 Trillium Therapeutics Inc
10.2 Leukocyte Surface Antigen CD47 Sales Date of Major Players (2017-2020e)
10.2.1 Aurigene Discovery Technologies Ltd
10.2.2 Celgene Corp
10.2.3 Forty Seven Inc
10.2.4 Surface Oncology Inc
10.2.5 Trillium Therapeutics Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LEUKOCYTE SURFACE ANTIGEN CD47 INDUSTRY
2.1 Summary about Leukocyte Surface Antigen CD47 Industry
2.2 Leukocyte Surface Antigen CD47 Market Trends
2.2.1 Leukocyte Surface Antigen CD47 Production & Consumption Trends
2.2.2 Leukocyte Surface Antigen CD47 Demand Structure Trends
2.3 Leukocyte Surface Antigen CD47 Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 B-6H12
4.2.2 ALX-148
4.2.3 CC-90002
4.2.4 PSTx-23
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Lymphoma
4.3.2 Ovarian Cancer
4.3.3 Ischemia Reperfusion Injury
4.3.4 Kindney Transplant Rejection
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 B-6H12
5.2.2 ALX-148
5.2.3 CC-90002
5.2.4 PSTx-23
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Lymphoma
5.3.2 Ovarian Cancer
5.3.3 Ischemia Reperfusion Injury
5.3.4 Kindney Transplant Rejection
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 B-6H12
6.2.2 ALX-148
6.2.3 CC-90002
6.2.4 PSTx-23
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Lymphoma
6.3.2 Ovarian Cancer
6.3.3 Ischemia Reperfusion Injury
6.3.4 Kindney Transplant Rejection
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 B-6H12
7.2.2 ALX-148
7.2.3 CC-90002
7.2.4 PSTx-23
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Lymphoma
7.3.2 Ovarian Cancer
7.3.3 Ischemia Reperfusion Injury
7.3.4 Kindney Transplant Rejection
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 B-6H12
8.2.2 ALX-148
8.2.3 CC-90002
8.2.4 PSTx-23
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Lymphoma
8.3.2 Ovarian Cancer
8.3.3 Ischemia Reperfusion Injury
8.3.4 Kindney Transplant Rejection
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 B-6H12
9.2.2 ALX-148
9.2.3 CC-90002
9.2.4 PSTx-23
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Lymphoma
9.3.2 Ovarian Cancer
9.3.3 Ischemia Reperfusion Injury
9.3.4 Kindney Transplant Rejection
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Aurigene Discovery Technologies Ltd
10.1.2 Celgene Corp
10.1.3 Forty Seven Inc
10.1.4 Surface Oncology Inc
10.1.5 Trillium Therapeutics Inc
10.2 Leukocyte Surface Antigen CD47 Sales Date of Major Players (2017-2020e)
10.2.1 Aurigene Discovery Technologies Ltd
10.2.2 Celgene Corp
10.2.3 Forty Seven Inc
10.2.4 Surface Oncology Inc
10.2.5 Trillium Therapeutics Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Leukocyte Surface Antigen CD47 Product Type Overview
2.Table Leukocyte Surface Antigen CD47 Product Type Market Share List
3.Table Leukocyte Surface Antigen CD47 Product Type of Major Players
4.Table Brief Introduction of Aurigene Discovery Technologies Ltd
5.Table Brief Introduction of Celgene Corp
6.Table Brief Introduction of Forty Seven Inc
7.Table Brief Introduction of Surface Oncology Inc
8.Table Brief Introduction of Trillium Therapeutics Inc
9.Table Products & Services of Aurigene Discovery Technologies Ltd
10.Table Products & Services of Celgene Corp
11.Table Products & Services of Forty Seven Inc
12.Table Products & Services of Surface Oncology Inc
13.Table Products & Services of Trillium Therapeutics Inc
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Leukocyte Surface Antigen CD47 Product Type Overview
2.Table Leukocyte Surface Antigen CD47 Product Type Market Share List
3.Table Leukocyte Surface Antigen CD47 Product Type of Major Players
4.Table Brief Introduction of Aurigene Discovery Technologies Ltd
5.Table Brief Introduction of Celgene Corp
6.Table Brief Introduction of Forty Seven Inc
7.Table Brief Introduction of Surface Oncology Inc
8.Table Brief Introduction of Trillium Therapeutics Inc
9.Table Products & Services of Aurigene Discovery Technologies Ltd
10.Table Products & Services of Celgene Corp
11.Table Products & Services of Forty Seven Inc
12.Table Products & Services of Surface Oncology Inc
13.Table Products & Services of Trillium Therapeutics Inc
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Leukocyte Surface Antigen CD47 Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Leukocyte Surface Antigen CD47 Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Leukocyte Surface Antigen CD47 Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Leukocyte Surface Antigen CD47 Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Leukocyte Surface Antigen CD47 Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Leukocyte Surface Antigen CD47 Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Leukocyte Surface Antigen CD47 Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Leukocyte Surface Antigen CD47 Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure PSTx-23 Segmentation Market Size (USD Millio
1.Figure Global Leukocyte Surface Antigen CD47 Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Leukocyte Surface Antigen CD47 Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Leukocyte Surface Antigen CD47 Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Leukocyte Surface Antigen CD47 Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Leukocyte Surface Antigen CD47 Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Leukocyte Surface Antigen CD47 Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Leukocyte Surface Antigen CD47 Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure PSTx-23 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Lymphoma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Ovarian Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Ischemia Reperfusion Injury Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Kindney Transplant Rejection Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure B-6H12 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure ALX-148 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure CC-90002 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure PSTx-23 Segmentation Market Size (USD Millio
